This allows FOXM1 to control the activity of anti-apoptotic genes like Bcl-2 and Survivin and to promote progression of the cell cycle, which supports cancer cell survival through replication defects and DNA damage that drive resistance to some chemotherapeutic drugs [62, 63]. This evidence concerns the gene FOXM1 and cancer.